NEW YORK, NY--(Marketwire - Feb 14, 2013) - Health Care stocks have been on an impressive run to start 2013. The Affordable Care Act will provide millions of Americans with access to healthcare, creating new revenue streams for companies across the sector. Research Driven Investing examines investing opportunities in the Health Care Sector and provides equity research on Centene Corp. (
Access to the full company reports can be found at:
The Affordable Care Act (Obamacare) requires every American to acquire health insurance by 2014 or be subjected to a tax. For those who can't afford health insurance they will be offered subsidies or Medicaid. Statistics from the Census Bureau show that approximately 50 million Americans did not have health insurance in 2009.
According to the Centers for Medicare and Medicaid Services total health care spending is projected to grow from an estimated $2.8 trillion last year to $4.8 trillion by 2021, an increase of 70 percent. "There's just a lot more money flowing into health care and we're seeing the markets react accordingly," says Invesco portfolio manager, Derek Taner.
Research Driven Investing releases regular market updates on the Health Care Sector so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.RDInvesting.com and get exclusive access to our numerous stock reports and industry newsletters.
Centene is a leading multi-line healthcare enterprise that provides programs and related services to the rising number of under-insured and uninsured individuals. The company reported premium and service revenues of $2.3 billion in the fourth quarter, a year-over-year increase of 58 percent. Shares of Centene have gained over 10 percent year-to-date.
Molina Healthcare provides quality and cost-effective Medicaid-related solutions to meet the health care needs of low-income families and individuals and to assist state agencies in their administration of the Medicaid program. The company swung to a net income of $25.6 million in the fourth quarter, compared to a net loss of $33 million a year ago.
Research Driven Investing has not been compensated by any of the above-mentioned publicly traded companies. Paragon Report is compensated by other third party organizations for advertising services. We act as an independent research portal and are aware that all investment entails inherent risks. Please view the full disclaimer at: